Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/43737
標題: CLINICAL GENOMICS IDENTIFIES THE EXPRESSION OF HUMAN OVARIAN CARCINOMA
作者: Tsai, M.H.
蔡孟勳
Huang, S.G.
Tsaur, S.C.
Hung, Y.C.
Chiu, S.H.
Wang, C.W.
關鍵字: borderline malignancy
expression profile
microarray
ovarian tumor
real-time reverse transcription polymerase chain reaction
gene-expression
cdna microarray
cancer
transcripts
profiles
patterns
growth
cells
期刊/報告no:: International Journal of Gerontology, Volume 3, Issue 3, Page(s) 163-169.
摘要: Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma are diagnosed in the advanced stages. Currently, no effective means of early detection are available. identifying genes that distinguish early cancers from normal tissue may provide insight to the initiation and progression of ovarian cancer. Methods: A large-scale gene expression profiling using 9,600 genes-complementary DNA array to study ovarian tumors was conducted. We analyzed 13 benign tumors, 22 invasive cancers (seven stage I and 15 stage III), and 16 normal ovaries. Cluster analysis revealed two major groups: the early-stage cluster that included 13 benign tumors and seven stage I cancers; and the late-stage cluster that included all stage III cancers. Results: There were 433 upregulated and 60 downregulated genes from the early-stage cluster, and 395 upregulated and 101 downregulated genes from the late-stage cluster. These genes showed altered functions for tumor/cancers, functions such as cell growth, cell cycle control, differentiation, signaling, apoptosis, ion transport, and morphogenesis. of most interest is the downregulation of nuclear receptor proteins. Differentially expressed genes between early-stage cluster and late-stage clusters were identified. We found 90 genes preferentially overly expressed and 165 genes relatively downregulated at late-stage cancers. The advanced cancer appears differently from early-stage cancer in cell growth, cell adhesion, hormone activity, morphology, and cell-cell signaling compared with benign or early-stage cancer. of particular interest are enzymes corresponding to pteridine biosynthesis, reported for the first time in this study. Real-time reverse transcription polymerase chain reaction showed that GCH1, KRT18, H3F3A, and MYBL2 were overly expressed in all cancer tissues, while MDFI, ARP3BETA, COL16A1, and MLN discriminated late-stage from early-stage cancers. Conclusion: The microarray provides valuable resources for comparing expression profiles of cancers at various stages and helps research the diagnosis and mechanism of ovarian cancer. [International journal of Gerontology 2009; 3(3): 163-169]
URI: http://hdl.handle.net/11455/43737
ISSN: 1873-9598
Appears in Collections:資訊管理學系

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.